제 품 PRODUCT

Inform your healthcare provider today if you (or your child): may not be viewing as well as before starting SABRIL; start to trip, run across things, or are more awkward than usual millirems to rems; are amazed by things or people coming in front of you that seem ahead out of nowhere; or if your baby is acting in a different way than typical.

The Vigabatrin REMS Program is required by the FDA to make sure notified risk-benefit decisions prior to initiating therapy, and to make certain proper use of vigabatrin while individuals are dealt with. When vision loss will certainly occur, it is not feasible for your medical care provider to understand.

It is recommended that your healthcare provider test your (or your youngster's) vision before or within 4 weeks after starting SABRIL and at least every 3 months throughout treatment till SABRIL is quit. If you or your youngster have any kind of side impact that troubles you or that does not go away, tell your medical care company.

If you are pregnant or plan to obtain pregnant, inform your medical care service provider. If vision screening can not be done, your healthcare provider may proceed suggesting SABRIL, but will certainly not have the ability to expect any type of vision loss. Your healthcare company may stop recommending SABRIL for you (or your youngster)if vision examinations are not done routinely.